JPS56101555A - Purification of lipoprotein cholesterol to use as cholesterol standard substance - Google Patents

Purification of lipoprotein cholesterol to use as cholesterol standard substance

Info

Publication number
JPS56101555A
JPS56101555A JP20481A JP20481A JPS56101555A JP S56101555 A JPS56101555 A JP S56101555A JP 20481 A JP20481 A JP 20481A JP 20481 A JP20481 A JP 20481A JP S56101555 A JPS56101555 A JP S56101555A
Authority
JP
Japan
Prior art keywords
cholesterol
purification
standard substance
lipoprotein
lipoprotein cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP20481A
Other languages
English (en)
Japanese (ja)
Other versions
JPS644621B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Emu Girugisu Makuramu
Ii Jiyakuson Deibitsudo
Jiee Mannuza Furanku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of JPS56101555A publication Critical patent/JPS56101555A/ja
Publication of JPS644621B2 publication Critical patent/JPS644621B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
JP20481A 1980-01-07 1981-01-06 Purification of lipoprotein cholesterol to use as cholesterol standard substance Granted JPS56101555A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/110,228 US4290774A (en) 1980-01-07 1980-01-07 Purification of lipoprotein cholesterol for use as a cholesterol reference material

Publications (2)

Publication Number Publication Date
JPS56101555A true JPS56101555A (en) 1981-08-14
JPS644621B2 JPS644621B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-01-26

Family

ID=22331904

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20481A Granted JPS56101555A (en) 1980-01-07 1981-01-06 Purification of lipoprotein cholesterol to use as cholesterol standard substance

Country Status (4)

Country Link
US (1) US4290774A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0031955B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS56101555A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3069532D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490228A1 (fr) * 1980-09-16 1982-03-19 Biomerieux Sa Procede de preparation de solutions de lipoproteines a partir de residus de delipidation des plasmas et serums sanguins et produits ainsi obtenus
WO1983003680A1 (en) * 1982-04-20 1983-10-27 Cooper Lab Method and composition for elevated lipid quality control materials
US4403042A (en) * 1982-08-19 1983-09-06 Miles Laboratories, Inc. Detection of cell membrane antigens and corresponding antibodies
HUT40311A (en) * 1983-06-03 1986-12-28 Kiskunhalasi Aag Process for producing protein concentrates, blood-curd and nutriments from blood and its elements
DE3330648C2 (de) * 1983-08-25 1986-11-20 Behringwerke Ag, 3550 Marburg Verfahren zum Abtrennen von Lipoproteinen mittels derivatisiertem Polyhydroxymethylen
DE3445010A1 (de) * 1984-12-10 1986-06-19 Boehringer Mannheim Gmbh Kontroll- bzw. eichserum fuer die lipid-diagnostik
US4758517A (en) * 1985-05-10 1988-07-19 Mobay Corporation Process for growth of treponema hyodysenteriae
CA1279593C (en) * 1985-05-10 1991-01-29 Makram Melek Girgis Cholesterol-rich fraction, process therefor and use thereof in cell culture
IL79945A (en) * 1986-09-04 1991-06-10 I D L International Diagnostic Method for the quantitative determination of total cholesterol in blood
GB8728310D0 (en) * 1987-12-03 1988-01-06 St Georges Hosp Medical School Method of estimation of systemic cholesterol concentrations from capillary blood samples
DE3928258A1 (de) * 1989-08-26 1991-02-28 Sueddeutsche Kalkstickstoff Verfahren zur entfernung von cholesterin bzw. cholesterinestern aus eigelb
US5292546A (en) * 1990-04-26 1994-03-08 Skw Trostberg Aktiengesellschaft Process for the removal of cholesterol from egg yolk
US5128162A (en) * 1990-07-31 1992-07-07 Kraft General Foods, Inc. Method for removing cholesterol from edible oils
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US6362003B1 (en) 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
AU4924193A (en) * 1992-09-24 1994-04-12 Perseptive Biosystems, Inc. Quantitative measurement of ldl
US5362649A (en) * 1993-02-16 1994-11-08 The United States Of America As Represented By The Secretary Of The Air Force Method for concentration based analysis of lipid fatty acids and its use in determining the likelihood that a patient is at risk for coronary artery disease
US5401466A (en) * 1993-06-01 1995-03-28 Miles Inc. Device for the direct measurement of low density lipoprotein cholesterol
US5409840A (en) * 1993-10-12 1995-04-25 Miles Inc. Purification and recovery of lipoprotein cholesterol
US5770451A (en) * 1995-03-30 1998-06-23 Streck Laboratories, Inc. Liquid lipoprotein control
US5614414A (en) * 1995-03-30 1997-03-25 Streck Laboratories, Inc. Liquid lipoprotein control
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
AU2002211544A1 (en) 2001-05-08 2002-11-18 Serologicals Royalty Company Process for inactivating prions in lipoproteins
US6569682B2 (en) 2001-07-27 2003-05-27 Coulter International Corp. Hematology control product with increased closed vial stability

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3728226A (en) * 1970-06-01 1973-04-17 Baxter Laboratories Inc Blood serum analytical control standard
LU65729A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-07-14 1974-01-21
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
US4110077A (en) * 1976-10-08 1978-08-29 Hoffmann-La Roche Inc. Determination of β-lipoproteins in blood serum with polyanethole sulfonate
US4210557A (en) * 1978-12-15 1980-07-01 Beckman Instruments, Inc. Non-high density lipoprotein precipitant

Also Published As

Publication number Publication date
JPS644621B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-01-26
EP0031955B1 (en) 1984-10-24
US4290774A (en) 1981-09-22
DE3069532D1 (en) 1984-11-29
EP0031955A1 (en) 1981-07-15

Similar Documents

Publication Publication Date Title
JPS56101555A (en) Purification of lipoprotein cholesterol to use as cholesterol standard substance
JPS55157377A (en) Method of purifying water liquid
GB2014985B (en) Purification of terephthalic acid
GB2047709B (en) Purification of cellulase
JPS54106412A (en) Method of purifying ester
JPS5553224A (en) Purification of distilling mixture
GB2075047B (en) Purification of oils
JPS5589252A (en) Purification of insulin
JPS55113797A (en) Purification of phosphorusthio acid ester
PL119268B2 (en) Method of purification of pyrazole compounds
JPS55154999A (en) Novel purification of ursodeoxycholic acid
JPS55143979A (en) Purification of mercaprobenzothiazole
GB2020551B (en) Use of silica gel for reducing blood lipid concentration
GB2072656B (en) Purification of arganic compounds
JPS5555159A (en) Purification of crude caprolactam
JPS5747497A (en) Purification of sugar solution
JPS5726661A (en) Purification of 2-pyrrolidone
JPS5581657A (en) Purifying waterrremoving method of blood
JPS5670097A (en) Purification of fatty acid
JPS5747498A (en) Purifying of sugar solution
GB2131015B (en) Purification of hydroquinone
JPS54125185A (en) Purification of brine
GB2024795B (en) Purification of effluent
JPS5632498A (en) Purification of chenodeoxycholic acid
JPS5615217A (en) Purification of nonreactive gas